Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541234
PUBLISHER: IMARC | PRODUCT CODE: 1541234
Irritable Bowel Syndrome Treatment Market Report by Type (IBS with Diarrhea, IBS with Constipation, Mixed IBS), Product, Distribution Channel, and Region 2024-2032
PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global irritable bowel syndrome treatment market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 8% during 2024-2032.
Irritable bowel syndrome (IBS) refers to a chronic medical condition that affects the large intestine. It is usually caused by severe infection, stressful lifestyle, changes in gut microbes, muscle contractions in the intestine, and abnormalities in the nervous system. It can be characterized by gas, diarrhea, cramping, bloating, constipation, weight loss, vomiting, abdominal pain, and difficulty in swallowing. Several medications are currently available to relieve mild symptoms of IBS, including rifaximin, loperamide, laxatives, antispasmodics, fiber supplements, and coated peppermint oil capsules. Doctors also recommend probiotics and mental health therapies, such as cognitive behavioral-therapy (CBT), gut-directed hypnotherapy, and relaxation training, to treat certain patients
Irritable Bowel Syndrome Treatment Market Trends:
Several factors increase the risk of IBS diseases, including food intolerances or sensitivities, bacterial infections in the digestive tract, small intestinal bacterial overgrowth, and mental disorders like anxiety, depression, and somatic symptom. This, along with improving diagnostic modalities and easy access to healthcare services, represents one of the key factors bolstering the growth of the market. Furthermore, IBS is one of the most common functional gastrointestinal disorders among the elderly. In confluence with this, the rising geriatric population across the globe is influencing the market positively. Besides this, several clinical trials, such as fecal microbiota transplantation (FMT), are being conducted to improve the treatment of IBS, which is contributing to market growth. In addition to this, as part of the Sustainable Development Goals (SDGs), governing agencies of various countries have pledged to substantially increase spending on research and development (R&D) projects and the number of researchers by 2030. This, in turn, is projected to expand the number of potential treatment options for IBS in the future.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global irritable bowel syndrome treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product and distribution channel.
Breakup by Type:
IBS with Diarrhea (IBS-D)
IBS with Constipation (IBS-C)
Mixed IBS
Breakup by Product:
Rifaximin
Eluxadoline
Lubiprostone
Linaclotide
Others
Breakup by Distribution Channel:
Hospitals Pharmacies
Drug Stores and Retail Pharmacies
Online Stores
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Allergan plc (AbbVie Inc.), Ardelyx Inc., Astellas Pharma Inc., AstraZeneca plc, Bausch Health Companies Inc., GlaxoSmithKline Plc, Novartis AG, Sebela Pharmaceuticals Inc., Synthetic Biologics Inc. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report:
- How has the global irritable bowel syndrome treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global irritable bowel syndrome treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global irritable bowel syndrome treatment market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112024A4297
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Irritable Bowel Syndrome Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 IBS with Diarrhea (IBS-D)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 IBS with Constipation (IBS-C)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Mixed IBS
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Product
- 7.1 Rifaximin
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Eluxadoline
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Lubiprostone
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Linaclotide
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospitals Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Drug Stores and Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Stores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Allergan plc (AbbVie Inc.)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Ardelyx Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 Astellas Pharma Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 AstraZeneca plc
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Bausch Health Companies Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 GlaxoSmithKline Plc
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Novartis AG
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Sebela Pharmaceuticals Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Synthetic Biologics Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.11 Takeda Pharmaceutical Company Limited
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
Product Code: SR112024A4297
List of Figures
- Figure 1: Global: Irritable Bowel Syndrome Treatment Market: Major Drivers and Challenges
- Figure 2: Global: Irritable Bowel Syndrome Treatment Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Type (in %), 2023
- Figure 5: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Product (in %), 2023
- Figure 6: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Distribution Channel (in %), 2023
- Figure 7: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Region (in %), 2023
- Figure 8: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Irritable Bowel Syndrome Treatment (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Irritable Bowel Syndrome Treatment (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: North America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: North America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: United States: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: United States: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Canada: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Canada: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Asia-Pacific: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Asia-Pacific: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: China: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: China: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Japan: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Japan: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: India: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: India: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: South Korea: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: South Korea: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Australia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Australia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Indonesia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Indonesia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Europe: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Europe: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Germany: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Germany: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: France: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: France: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: United Kingdom: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: United Kingdom: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Italy: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Italy: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Spain: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Spain: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Russia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Russia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Latin America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Latin America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Brazil: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Brazil: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Mexico: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Mexico: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Breakup by Country (in %), 2023
- Figure 78: Middle East and Africa: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Global: Irritable Bowel Syndrome Treatment Industry: SWOT Analysis
- Figure 80: Global: Irritable Bowel Syndrome Treatment Industry: Value Chain Analysis
- Figure 81: Global: Irritable Bowel Syndrome Treatment Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Irritable Bowel Syndrome Treatment Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Product (in Million US$), 2024-2032
- Table 4: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
- Table 5: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Irritable Bowel Syndrome Treatment Market: Competitive Structure
- Table 7: Global: Irritable Bowel Syndrome Treatment Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.